Come up with a name for your new list and we'll add to it:
Exscien Corporation raised a round of funding on August 16, 2017. Investors include
National Heart Lung and Blood Institute.
Exscien Corporation develops protein technologies that address the consequences resulting from Reactive Oxygen Species (ROS) induced damage.…